JPMorgan Chase & Co’s Whitehawk Therapeutics, Inc. Common Stock WHWK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $787 | Sell |
421
-1,341
| -76% | -$2.51K | ﹤0.01% | 5758 |
|
|
2025
Q1 | $3.14K | Buy |
1,762
+284
| +19% | +$505 | ﹤0.01% | 5617 |
|
|
2024
Q4 | $4.66K | Sell |
1,478
-2,759
| -65% | -$8.7K | ﹤0.01% | 5479 |
|
|
2024
Q3 | $8.73K | Buy |
4,237
+3,816
| +906% | +$7.86K | ﹤0.01% | 5342 |
|
|
2024
Q2 | $615 | Sell |
421
-6,573
| -94% | -$9.6K | ﹤0.01% | 5645 |
|
|
2024
Q1 | $16.4K | Sell |
6,994
-3,554
| -34% | -$8.32K | ﹤0.01% | 5268 |
|
|
2023
Q4 | $21.3K | Hold |
10,548
| – | – | ﹤0.01% | 5232 |
|
|
2023
Q3 | $51.1K | Sell |
10,548
-2,814
| -21% | -$13.6K | ﹤0.01% | 4907 |
|
|
2023
Q2 | $91.4K | Buy |
13,362
+2,234
| +20% | +$15.3K | ﹤0.01% | 4678 |
|
|
2023
Q1 | $80K | Buy |
11,128
+2,896
| +35% | +$20.8K | ﹤0.01% | 4737 |
|
|
2022
Q4 | $105K | Buy |
8,232
+319
| +4% | +$4.07K | ﹤0.01% | 4481 |
|
|
2022
Q3 | $112K | Buy |
7,913
+171
| +2% | +$2.42K | ﹤0.01% | 4425 |
|
|
2022
Q2 | $95K | Buy |
+7,742
| New | +$95K | ﹤0.01% | 4656 |
|
|
2020
Q4 | – | Sell |
-427
| Closed | -$10K | – | 5136 |
|
|
2020
Q3 | $10K | Buy |
+427
| New | +$10K | ﹤0.01% | 4595 |
|
|
2019
Q2 | – | Sell |
-320
| Closed | -$4K | – | 4968 |
|
|
2019
Q1 | $4K | Buy |
+320
| New | +$4K | ﹤0.01% | 4729 |
|